Search results

Page results

• Welfare and benefits advice for people affected by cancer or a blood condition

  Advice about available financial support and how to apply for it.

• Wellbeing activities for people affected by cancer or a blood condition

  A programme of wellbeing classes, workshops and courses. It includes activities which give advice and/or support to help people to manage the physical and emotional impact of cancer or a blood condition.

• New patient information

  Information for new neuro-otology patients

• Brooke Robinson – neuroradiographer

  Brooke Robinson tells us what it is like to work to in neuroradiography at the National Hospital for Neurology and Neurosurgery.

• EpicCare Link UCLH

  GP portal (now called EpicCare Link UCLH) allows GPs to access information about patients they have referred to UCLH.

• GP news

  News and updates for primary care professionals working with, and referring to, UCLH.

• COVID-19 treatments for highest risk non-hospitalised patients

  We are now administering new COVID-19 treatments for patients at highest risk in the community. The service can prescribe oral antivirals to be taken at home, and give intravenous antibody treatments at the hospital.

• Diabetes

  We work together closely to support and improve the health of people with type 1 and type 2 diabetes via education, training, research and through other services that we provide. Our team works in close collaboration with ophthalmologists, vascular surgeons, endocrine surgeons, obstetricians and paediatricians.

• Molecular Radiotherapy Series No. 6 - Information for parents of children and young people having radioactive iodine (131I) treatment

  This page is for parents, carers and family members who are acting as comforters and carers for children and young people having radioactive iodine (131I) treatment. It explains what the treatment involves, how to prepare for it and what you can expect afterwards.

• First participant joins new Parkinson’s Disease study at UCLH

  UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.